Skip to main content

Table 1 Demographic and laboratory characteristics in all stroke, favorable and poor outcome groups

From: Predictive value of circulating interleukin-6 and heart-type fatty acid binding protein for three months clinical outcome in acute cerebral infarction: multiple blood markers profiling study

Characteristic All
(number = 175)
Favorable
(number 111)
Poor
(number = 64)
P
Age (years old) 66 ± 11 64 ± 11 69 ± 10 0.002
Sex (male, %) 95 (54.3) 56 (50.5) 39 (60.9) 0.21
Initial NIHSS score 5 (3 to 10) 4 (2 to 5) 12 (7 to 16) < 0.001a
72 hour-infarct volume (ml)b 5.9 (1.4 to 35.0) 3 (1 to 9) 55 (5 to 215) < 0.001a
Sampling time (hours) 10 (7 to 16) 10 (7 to 17) 11 (8 to 15) 0.66a
Hypertension (%) 101 (57.7) 61 (55.0) 40 (62.5) 0.35
Diabetes mellitus (%) 53 (30.3) 36 (32.4) 17 (26.6) 0.50
Hyperlipidemia (%) 42 (24.0) 26 (23.4) 16 (25.0) 0.81
Heart failure (%) 17 (9.7) 8 (7.2) 9 (14.1) 0.19
Atrial fibrillation (%) 53 (30.3) 21 (18.9) 32 (50.0) < 0.001
Smoking (%) 71 (40.6) 47 (42.3) 24 (37.5) 0.63
Previous statin use (%) 26 (14.9) 17 (15.3) 9 (14.1) 0.99
Systolic BP (mmHg) 134 ± 19 134 ± 19 133 ± 18 0.68
Diastolic BP (mmHg) 82 ± 12 81 ± 10 83 ± 14 0.21
Creatinine (mg/dl) 1.07 ± 0.56 1.04 ± 0.62 1.11 ± 0.42 0.46
Fasting glucose (mg/dl) 138 ± 55 135 ± 57 143 ± 53 0.37
LDL cholesterol (mg/dl) 115 ± 37 118 ± 29 109 ± 47 0.17
WBC (103/μl) 7.8 ± 3.0 7.7 ± 2.7 9.2 ± 3.7 < 0.01
TOAST     < 0.01
   LAA 52 (29.7) 35 (31.5) 17 (26.6)  
   CE 49 (28.0) 25 (22.5) 24 (37.5)  
   SVD 38 (21.7) 34 (30.6) 4 (6.3)  
   Others 36 (20.6) 17 (15.3) 19 (29.7)  
  1. aStatistical analysis conducted using the Mann-Whitney U test; bhyperintense lesion on diffusion-weighted image 72 hours after stroke. BP, blood pressure; CE, cardioembolism; LAA, large-artery atherosclerosis; LDL, low density lipoprotein cholesterol; NIHSS, National Institutes of Health Stroke Scale; SVD, small vessel disease; TOAST, Trial of Org10172 in the Acute Stroke Treatment; WBC, white blood cell.